|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real estate assets | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Building, fixtures and improvements | ||||||||||||||||||||
| Intangible lease assets | ||||||||||||||||||||
| Less: accumulated depreciation and amortization | ||||||||||||||||||||
| Total real estate assets, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investments, at fair value | ||||||||||||||||||||
| Unconsolidated investment (non-security), at fair value | ||||||||||||||||||||
| Equity method investments, at fair value | ||||||||||||||||||||
| Investments income, rents and other receivables | ||||||||||||||||||||
| Investment acquisition advance | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Assets held for sale, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Securities sold, not yet purchased, at fair value | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Mortgage notes payable, net | ||||||||||||||||||||
| Line of credit and notes payable, net | ||||||||||||||||||||
| Line of credit, net | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Deferred rent and other liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Dividend payable | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Stock redemption payable | ||||||||||||||||||||
| Below-market lease liabilities, net | ||||||||||||||||||||
| Due to related entities | ||||||||||||||||||||
| Contingent liability | ||||||||||||||||||||
| Capital pending acceptance | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total capital pending acceptance | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock, $0.0001 par value, 80,000,000 shares authorized; 2,512,270.00 and 1,578,192.98 shares issued and outstanding as of June 30, 2026 and June 30, 2025, respectively. | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total preferred stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
